The 13-valent vaccine for young kids was shown more effective than the 23-valent version for older adults.
A 66-year-old United Arab Emirates (UAE) man who owns camels has the latest confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, the World Health Organization (WHO) announced in a statement today.
Saudi Arabia's health ministry today announced two more Middle East respiratory syndrome coronavirus (MERS-CoV) infections, one of which appears to be in a health worker with an asymptomatic infection who had contact with a confirmed case, according to a machine-translation of a statement posted on the ministry's Web site.
WHO-led malaria vaccine development group announces new goals and a wish list for future vaccines.
The World Health Organization (WHO) today confirmed a fatal case of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia, adding to information in an Oct 31 statement from the Saudi government about the death of a 56-year-old.
A rapid tuberculosis (TB) test that was endorsed by the World Health Organization (WHO) speeded the start of treatment but did not reduce TB-related illness in a field trial in four African countries, according to a study released yesterday in The Lancet.
A federal advisory group today approved a measure to include a new meningococcal vaccine option for youngsters ages 2 months and older at risk for meningitis infection.
Saudi Arabia has reported two more Middle East respiratory syndrome coronavirus (MERS-CoV) cases in the past few days, both in men living in the Riyadh region, according to a press account and a translated government statement.
Clusters of children who had nonmedical exemptions (NMEs) from vaccines appears to be one of several factors that played a role in California's 2010 pertussis (whooping cough) epidemic, researchers reported today in Pediatrics.
The World Health Organization (WHO) yesterday recommended a specific H7N9 influenza strain for vaccine development, saying it "elicits antibodies that react well with all viruses tested."
In a statement, the WHO said it has selected an A/Anhui/1/2013-like virus for the development of H7N9 vaccines for pandemic preparedness. It notes that A/Shanghai/2/2013 is an A/Anhui/1/2013-like virus.
